Skip to main content

Table 9 Change from Baseline in Triglycerides and Total Cholesterol

From: Efficacy and tolerability of atypical antipsychotics for acute bipolar depression: a network meta-analysis

PLO 0.98 [− 10.48, 12.47] 1.35 [− 1.27, 6.50] 1.85 [− 1.88, 8.64] 11.10 [− 2.75, 24.86] − 3.05 [− 15.37, 9.55]
0.50 [−5.64, 6.60] ARI 0.37 [− 11.45, 12.83] 0.87 [− 11.26, 13.80] 10.12 [−7.63, 28.42] −4.03 [− 21.02, 12.83]
− 2.05 [− 5.90, 1.67] − 2.55 [−9.87, 4.56] CAR 0.50 [− 5.46, 6.84] 9.75 [− 4.84, 24.02] − 4.40 [− 17.54, 8.47]
7.06 [2.47, 12.00] 6.55 [− 1.05, 14.47] 9.11 [3.22, 15.46] OLA 9.25 [− 5.75, 23.54] − 4.89 [− 18.60, 8.37]
0.50 [− 4.86, 5.88] 0.00 [−8.13, 8.18] 2.55 [− 3.96, 9.20] −6.55 [− 13.85, 0.46] QUE − 14.15 [− 32.40, 4.08]
1.72 [−6.56, 9.94] 1.22 [− 9.02, 11.51] 3.77 [−5.24, 12.88] − 5.34 [− 14.99, 4.03] 1.21 [− 8.64, 10.98] LUR
  1. Note: Triglycerides results are on the top-right and Total Cholesterol results are on the bottom-left. Numbers represent the mean change [95% credible interval]. In the top-right comparisons, the row treatment is the reference category. In the bottom-left, the column treatment is the reference category
  2. Abbreviations: PLO Placebo, ARI Aripiprazole, CAR Cariprazine, LUR Lurasidone, OLA Olanzapine, QUE Quetiapine